Niquitin Omega Pharma (Nicotine)

Nicotine acts as an agonist at nicotinic acetylcholine receptors in the brain and peripheral nervous system. By stimulating these receptors, it releases dopamine and other neurotransmitters, partially mimicking the effect of tobacco smoke and thereby decreasing the intensity of withdrawal and the urge to smoke.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and clinical response. Dosing regimens are tailored to each patient and should follow the prescriber’s instructions.

Safety data for nicotine replacement products in pregnancy and lactation are limited. Use is generally avoided unless the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a qualified healthcare provider is essential before use.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Niquitin Omega Pharma delivers nicotine via the oromucosal route, providing rapid absorption similar to nicotine gum or lozenges. Compared with transdermal patches, it offers quicker onset of action but may require more frequent dosing. Choice of product depends on patient preference, tolerability and the desired speed of nicotine delivery.

Store the product at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep out of reach of children and do not use if the packaging is damaged or the product appears discoloured.

The medication is administered by placing the oromucosal formulation in the mouth and allowing it to dissolve slowly, avoiding swallowing immediately. Patients should follow the prescriber’s instructions regarding frequency and duration of use to achieve optimal cessation outcomes.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, cardiovascular events like chest pain or arrhythmia, seizures, and significant hypotension. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to nicotine or any excipients in the formulation should avoid use. It is also contraindicated in patients who have experienced recent myocardial infarction, uncontrolled hypertension, or severe cardiovascular disease without medical supervision.